Slovenia resumes use of AstraZeneca vaccine after brief suspension

Ljubljana – Slovenia has decided to resume using the AstraZeneca vaccine after the European Medicines Agency (EMA) assessed AstraZeneca’s Covid-19 vaccine “safe and effective” after a review of possible blood clot risks.

“The EMA has fund that the AstraZeneca vaccine is safe and efficient. Today we’ll notify vaccination centres to resume vaccination,” Health Minister Janez Poklukar told the press on Thursday.

Slovenia opted for a suspension on Monday after reports of blood clots led many European countries to halt the vaccination pending an additional review by the EMA.

Senior officials will be among the first to get the jab, the government announced on Twitter.

President Borut Pahor, Prime Minister Janez Janša, National Assembly Speaker Igor Zorčič and National Council President Alojz Kovšča will get the jab tomorrow afternoon.

After the suspension, Slovenia has over 14,000 shots of the AstraZeneca vaccine on store.

So far about one percent of those who were vaccinated with AstraZeneca in Slovenia have reported adverse effects, roughly the same share as those who receive the Pfizer/BioNTech vaccine.